Us Bancorp \De\ Biotechnology

Us Bancorp \De\

$75.6 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SMMT Summit Therapeutics Inc.	$4.09B	$2,000 0.0% of portfolio	163	Q4 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$56M	$1,000 0.0% of portfolio	693	Q4 2024 Reduced 31.59%
ALLO Allogene Therapeutics, Inc.	$223M	$1,000 0.0% of portfolio	739	Q4 2024 Reduced 58.53%
BCRX Biocryst Pharmaceuticals Inc	$1.46B	$1,000 0.0% of portfolio	210	Q4 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$118M	$1,000 0.0% of portfolio	247	Q4 2024 Reduced 75.35%
LXRX Lexicon Pharmaceuticals, Inc.	$108M	$1,000 0.0% of portfolio	1,624	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$171M	$1,000 0.0% of portfolio	277	Q4 2024 New
RGNX Regenxbio Inc.	$338M	$1,000 0.0% of portfolio	130	Q4 2024 Reduced 94.76%
STOK Stoke Therapeutics, Inc.	$284M	$1,000 0.0% of portfolio	114	Q4 2024 Reduced 38.04%
TSHA Taysha Gene Therapies, Inc.	$88M	$1,000 0.0% of portfolio	728	Q4 2024 Reduced 15.35%
MGTX Meira G Tx Holdings PLC	$330M	$0 0.0% of portfolio	38	Q4 2024 New
URGN Uro Gen Pharma Ltd.	$255M	$0 0.0% of portfolio	47	Q3 2024 Reduced 72.35%
IMTX Immatics N.V.	$353M	$0 0.0% of portfolio	126	Q4 2024 Reduced 38.24%
ANIX Anixa Biosciences Inc	$91.1M	$0 0.0% of portfolio	400	Q2 2022 Reduced 97.07%
ARQT Arcutis Biotherapeutics, Inc.	$947M	$0 0.0% of portfolio	24	Q4 2024 New
ATHA Athira Pharma, Inc.	$11.3M	$0 0.0% of portfolio	815	Q1 2024 New
AURA Aura Biosciences, Inc.	$186M	$0 0.0% of portfolio	27	Q4 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$59.4M	$0 0.0% of portfolio	33	Q4 2024 Reduced 99.82%
CCCC C4 Therapeutics, Inc.	$85.6M	$0 0.0% of portfolio	56	Q4 2024 Added 47.37%
SAVA Cassava Sciences Inc	$66.2M	$0 0.0% of portfolio	266	Q4 2024 Reduced 17.65%
CDXS Codexis, Inc.	$184M	$0 0.0% of portfolio	160	Q2 2023 Reduced 44.25%
FATE Fate Therapeutics Inc	$82.5M	$0 0.0% of portfolio	437	Q4 2024 Reduced 25.68%
FGEN Fibrogen Inc	$29.1M	$0 0.0% of portfolio	29	Q4 2024 Reduced 99.66%
IGMS Igm Biosciences, Inc.	$35.9M	$0 0.0% of portfolio	26	Q4 2024 Reduced 71.11%
LYEL Lyell Immunopharma, Inc.	$134M	$0 0.0% of portfolio	1,165	Q1 2024 New
MREO Mereo Biopharma Group PLC	$297M	$0 0.0% of portfolio	13	Q2 2024 Reduced 96.85%
GLUE Monte Rosa Therapeutics, Inc.	$238M	$0 0.0% of portfolio	26	Q4 2024 New
OCGN Ocugen, Inc.	$173M	$0 0.0% of portfolio	1,238	Q4 2024 Reduced 24.42%
ORIC Oric Pharmaceuticals, Inc.	$249M	$0 0.0% of portfolio	27	Q4 2024 New
PSTX Poseida Therapeutics, Inc.	$815M	$0 0.0% of portfolio	26	Q4 2024 New
PBYI Puma Biotechnology, Inc.	$143M	$0 0.0% of portfolio	200	Q3 2021 Reduced 60.78%
SANA Sana Biotechnology, Inc.	$325M	$0 0.0% of portfolio	538	Q4 2024 Reduced 17.23%
SGMO Sangamo Therapeutics, Inc	$128M	$0 0.0% of portfolio	23	Q3 2024 Reduced 95.7%
SVRA Savara Inc	$325M	$0 0.0% of portfolio	114	Q2 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	934	Q4 2024 Reduced 95.0%
VERA Vera Therapeutics, Inc.	$720M	$0 0.0% of portfolio	5	Q4 2024 New
XBIT X Biotech Inc.	$94.4M	$0 0.0% of portfolio	100	Q2 2024 New
YMAB Y M Abs Therapeutics, Inc.	$210M	$0 0.0% of portfolio	23	Q4 2024 Added 35.29%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.